The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Kymab
Cambridge, United Kingdom
A
101-250 Employees
2010
Key takeaway
Kymab, a Sanofi company based in Cambridge, UK, is focused on developing novel human antibody-based therapies, including bispecific antibodies, which are designed to be smarter and more effective medicines. Their unique platforms generate a wide range of fully-human antibodies, enhancing opportunities in therapeutic antibody and vaccine development.
Reference
Product
Bispecific antibodies
LiliumX
United Kingdom
A
1-10 Employees
2021
Key takeaway
The company specializes in treating solid tumors using bispecific antibody-drug conjugates, highlighting their innovative approach to drug design and discovery in this area.
Reference
Core business
Home
The Antibody Company Ltd
Motherwell, United Kingdom
A
1-10 Employees
-
Key takeaway
The Antibody Company specializes in the production and purification of antibodies, with over 20 years of experience in developing monoclonal antibodies for research and therapeutic applications. Their expertise in antibody engineering and integrated facilities positions them as a trusted partner for companies in need of high-quality antibodies.
Reference
Core business
The Antibody Company – Experts in the production, purification and conjugation of antibodies
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Fusion Antibodies
Belfast, United Kingdom
A
11-50 Employees
2001
Key takeaway
Fusion Antibodies is a leader in antibody development services, focusing on the discovery and engineering of biologics, which may include bispecific antibodies. With over 20 years of experience, they provide a comprehensive service from antigen design to cell line development, ensuring a strong emphasis on developability and manufacturability.
Reference
Core business
About Us | Fusion Antibodies
Fusion Antibodies are world leaders with over 20 years experience in antibody development services specializing in the discovery, engineering and supply of pre-clinical biologics through to clinical Cell Line Development.
Antikor
Stevenage, United Kingdom
A
11-50 Employees
2014
Key takeaway
Antikor's innovative OptiLinkTM platform enhances the development of Antibody Fragment Drug Conjugates (FDCs), which could significantly advance solid tumor therapies. Their approach promises a broader therapeutic window compared to traditional ADCs, making it a key player in the evolving landscape of bispecific antibodies in oncology.
Reference
Core business
Antibody Drug Conjugates | Antikor
Tresars
London, United Kingdom
A
1-10 Employees
2019
Key takeaway
Tresars LTD emphasizes their capability to provide a wide range of antibodies tailored to specific research needs, indicating their commitment to supporting innovative scientific endeavors.
Reference
Core business
Non-Animal Derived Antibody Manufacturer | Tresars
Scotia Biologics
Aberdeen City, United Kingdom
A
1-10 Employees
2012
Key takeaway
Scotia Biologics Ltd. specializes in custom antibody production and has over 20 years of experience in antibody engineering. Their expertise in developing high-affinity antibodies and recombinant proteins could be highly relevant for those interested in bispecific antibodies.
Reference
Core business
Antibody Engineering | Scotia Biologics Ltd. | Scotland
Scotia Biologics is the antibody engineering service that provides you with the exact antibody you need to test and validate your target so you can progress your research projects without wasting months working through catalogue or polyclonal antibody options
RxBiologics
Cambridge, United Kingdom
A
11-50 Employees
-
Key takeaway
RxBiologics specializes in antibody drug discovery services and utilizes its proprietary Galaxy® Antibody Discovery Platform to rapidly generate high-quality biologics. This platform supports the development of novel therapeutics, including bispecific antibodies, from early discovery through preclinical phases.
Reference
Core business
Home - RxBiologics DELIVERY OF NOVEL THERAPEUTICS |
At inception, human antibody phage display technology promised delivery of fully human antibodies, to any given target, directly from ...
ANTIBODY PRODUCTION SERVICES LIMITED
United Kingdom
A
1-10 Employees
-
Key takeaway
The company, Antibody Production Services (APS), specializes in the custom production and development of antibodies, including both monoclonal and polyclonal types. With over 40 years of experience and multiple quality accreditations, APS offers a comprehensive range of antibody-related services.
Reference
Core business
HOME - Antibody Production - Monoclonal - Polyclonal
A leading provider for flexible and professional contract development of quality antibodies both monoclonal and polyclonal.
NovalGen
London, United Kingdom
A
11-50 Employees
2019
Key takeaway
NovalGen is an innovative immuno-oncology company that is developing breakthrough bispecific antibody therapies aimed at safely harnessing the immune system to combat cancer. Their focus on proprietary treatments for hematologic malignancies and solid tumors highlights their commitment to advancing cancer therapy through cutting-edge bispecific technologies.
Reference
Core business
NovalGen – Breakthrough bispecific antibody therapies to treat cancer
NovalGen is an innovative immuno-oncology company focused on bispecific antibody approaches to fight cancer.
Technologies which have been searched by others and may be interesting for you:
When exploring the bispecific antibody industry in the United Kingdom, several key considerations are essential. The regulatory landscape is crucial, as the UK follows stringent guidelines set by the Medicines and Healthcare products Regulatory Agency (MHRA) and must comply with both local and European Union regulations post-Brexit. This regulatory framework influences clinical trial approvals and market entry strategies. Additionally, understanding the competitive landscape is vital; numerous companies, including both established pharmaceutical giants and innovative biotech firms, are actively developing bispecific antibodies for various therapeutic areas, particularly oncology. Challenges such as manufacturing complexities and high development costs are significant factors in this industry, impacting the scalability and economic feasibility of projects. However, opportunities abound, particularly due to increasing investments in biopharmaceutical research and a growing focus on personalized medicine. The UK is recognized for its robust research infrastructure and access to skilled professionals, fostering collaboration between academia and industry. Environmental concerns also play a role, as companies must navigate sustainability practices in production processes. Finally, the global market relevance of bispecific antibodies continues to expand, driven by advancements in technology and increasing demand for targeted therapies, positioning the UK as a competitive player in this evolving field.
Some interesting numbers and facts about your company results for Bispecific Antibody
| Country with most fitting companies | United Kingdom |
| Amount of fitting manufacturers | 445 |
| Amount of suitable service providers | 313 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 2001 |
| Youngest suiting company | 2021 |
Some interesting questions that has been asked about the results you have just received for Bispecific Antibody
What are related technologies to Bispecific Antibody?
Based on our calculations related technologies to Bispecific Antibody are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of Bispecific Antibody?
Start-Ups who are working in Bispecific Antibody are LiliumX
Which industries are mostly working on Bispecific Antibody?
The most represented industries which are working in Bispecific Antibody are Biotechnology, Pharmaceuticals, Other, Medical, Healthcare
How does ensun find these Bispecific Antibody Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
